Sorry, I don't understand your search. ×
Back to Search Start Over

Endocardial ablation of ganglionated plexus for the treatment of carotid sinus syndrome.

Authors :
Minguito‐Carazo, Carlos
Martínez‐Alday, Jesús Daniel
Seara, Javier García
Martínez‐Sande, José Luis
González‐Ferrero, Teba
Shangutov, Oleksandr
Elices‐Teja, Juliana
López, X. Alberte Fernández
González‐Juanatey, José Ramón
Rodríguez‐Mañero, Moisés
Source :
Journal of Cardiovascular Electrophysiology. Oct2024, p1. 10p. 5 Illustrations.
Publication Year :
2024

Abstract

Introduction Methods Results Conclusions Carotid sinus syndrome (CSS), characterized by exaggerated vagal responses leading to asystolic pauses with carotid sinus massage (CSM), often necessitates pacemaker implantation. This study investigates cardioneuroablation (CNA) as an alternative strategy for CSS.Prospective study of consecutive patients referred for CNA due to CSS. All patients underwent CSM, atropine test and 24‐h Holter monitoring before the procedure and at 6 months. The primary objective was the absence of any cardioinhibitory response to CSM following CNA. Secondary objectives included the combined endpoint of syncope and presyncope‐free survival, pacemaker‐free survival, differences in heart rate variation (HRV), as well as differences in the pre‐ and postprocedure atropine tests and in the SF‐36 quality‐of‐life questionnaire.A total of 13 consecutive patients (84.6% male, mean age 63.8 ± 12.3 years) were included. CSM revealed a symptomatic asystolic pause in all patients before CNA (7.3 [5.6–10.5] s). After the procedure, all the patients had a negative CSM, and only one patient (7.7%) had a positive CSM at 6 months. After a median follow‐up of 11.2 (10.6–16.3) months, syncope or presyncope‐free survival was 84.6%, and none required pacemaker implantation. There was an improvement in the energy and health change items in the SF‐36 questionnaire. There was a reduction in HR increase in the atropine test at 6 months (pre‐CNA: 66% [52–84] vs. post‐CNA 26.0% (19.8–29.3]; <italic>p</italic> = .008) and in HRV parameters.In this proof‐of‐efficacy study, performed in patients affected by asystolic CSS, CNA was effective in reducing the rate of cardioinhibitory responses, suggesting a potential efficacy in also reducing syncopal recurrences. Controlled trials are warranted to corroborate clinical findings. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10453873
Database :
Academic Search Index
Journal :
Journal of Cardiovascular Electrophysiology
Publication Type :
Academic Journal
Accession number :
180316706
Full Text :
https://doi.org/10.1111/jce.16469